This analysis of the Anastrazole or Tamoxifen Alone or Combined trial of early stage estrogen receptor-positive, ERBB2-negative #BreastCancer compares the predictive value for 6 different prognostic signature tests. http://ja.ma/2BZjct7
Social Media
This analysis of the Anastrazole or Tamoxifen Alone or Combined trial of early stage estrogen receptor-positive, ERBB2-negative #BreastCancer compares the predictive value for 6 different prognostic signature tests. http://ja.ma/2BZjct7
0 commenti:
Posta un commento